![Insights from 2023 ASH Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/12/d8f4a042-951d-471d-8892-527b15ad5587.png.200x0_q85.png)
Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
Efficacy of Ibrutinib Arms Across ALPINE and ELEVATE-RR Trials in R/R CLL: A Matching-Adjusted Indirect Comparison
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mazyar Shadman
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mazyar Shadman
762 views
December 19, 2023
Login to view comments.
Click here to Login
Leukemia